e-learning
resources
2020
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Volatile organic compound breath signatures of children with cystic fibrosis by real-time SESI-HRMS
Ronja Weber, Naemi Haas, Astghik Baghdasaryan, Tobias Bruderer, Demet Inci, Srdjan Micic, Nathan Perkins, Renate Spinas, Renato Zenobi, Alexander Moeller
Source:
ERJ Open Res, 6 (1) 00171-2019; 10.1183/23120541.00171-2019
Journal Issue:
January
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ronja Weber, Naemi Haas, Astghik Baghdasaryan, Tobias Bruderer, Demet Inci, Srdjan Micic, Nathan Perkins, Renate Spinas, Renato Zenobi, Alexander Moeller. Volatile organic compound breath signatures of children with cystic fibrosis by real-time SESI-HRMS. ERJ Open Res, 6 (1) 00171-2019; 10.1183/23120541.00171-2019
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Volatile organic compounds in the exhaled breath of young patients with cystic fibrosis
Source: Eur Respir J 2006; 27: 929-936
Year: 2006
Diagnostic potential of organic halides as breath biomarkers in cystic fibrosis
Source: Annual Congress 2007 - Clinical outcome studies and technical aspects of paediatric lung function testing
Year: 2007
Detection of elevated 2-propanol in breath samples from children with cystic fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 309s
Year: 2006
Comprehensive analysis of volatile organic compounds in human breath gas samples
Source: Eur Respir J 2003; 22: Suppl. 45, 131s
Year: 2003
Real-time exhaled breath analysis identifies altered metabolic signature in cystic fibrosis
Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring
Year: 2017
Analysis of semi-volatile organic compounds in exhaled breath condensate of patients with obstructive lung diseases
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Volatile organic compounds (VOC) in exhaled breath of patients with COPD
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010
Volatile organic compounds in exhaled breath are associated with exacerbations in children with asthma
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009
Volatile organic compounds in exhaled breath in preschool children with and without recurrent wheeze
Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma
Year: 2009
Exhaled volatile organic compounds in idiopathic pulmonary fibrosis and disease progression
Source: Virtual Congress 2020 – Biomarkers and mechanistic aspects of idiopathic pulmonary fibrosis
Year: 2020
Volatile organic compounds (VOCs) in COPD patients with exacerbation
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
Integrating monitoring of volatile organic compounds (VOCs) in asthma and COPD into the routine lung function
Source: International Congress 2015 – The next generation of lung function tests
Year: 2015
Value of exhaled volatile organic compounds in monitoring airway disease
Source: School Course 2013 - Monitoring of asthma, COPD and other airway diseases
Year: 2013
Volatile markers of pulmonary tuberculosis in the breath
Source: Annual Congress 2004 - Genetics and immunology of tuberculosis
Year: 2004
Ionic composition of exhaled breath condenesate in cystic fibrosis
Source: Eur Respir J 2001; 18: Suppl. 33, 8s
Year: 2001
Semi-volatile organic compounds in exhaled breath condensate: a new approach in the differential diagnosis of asthma and COPD
Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches
Year: 2009
Volatile organic compounds (VOC) in exhaled breath in patients with lung cancer, using the analytical technique thermal desorber- gase chromatography-spectrometer mases
Source: Annual Congress 2012 - New biomarkers for lung cancer
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept